BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11481276)

  • 1. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance.
    Kivelä T; Eskelin S; Mäkitie T; Summanen P
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2085-93. PubMed ID: 11481276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
    Mäkitie T; Carpén O; Vaheri A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2442-9. PubMed ID: 11581181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
    Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic report of uveal melanoma with persistent exudative retinal detachment after gamma knife radiosurgery.
    Song WK; Yang WI; Byeon SH; Koh HJ; Kwon OW; Lee SC
    Ophthalmologica; 2010; 224(1):16-21. PubMed ID: 19684424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.
    Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF
    Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body.
    Al-Jamal RT; Mäkitie T; Kivelä T
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2381-9. PubMed ID: 12766034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
    Seregard S; Spångberg B; Juul C; Oskarsson M
    Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.
    Char DH; Bove R; Phillips TL
    Trans Am Ophthalmol Soc; 2003; 101():53-6; discussion 56-7. PubMed ID: 14971563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic model and staging for metastatic uveal melanoma.
    Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
    Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal breaks and detachment after neodymium: YAG laser posterior capsulotomy: five-year incidence in a prospective cohort.
    Ranta P; Tommila P; Kivelä T
    J Cataract Refract Surg; 2004 Jan; 30(1):58-66. PubMed ID: 14967269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
    Braun UC; Rummelt VC; Naumann GO
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.